Preferential Misincorporation of Purine Nucleotides by Human DNA Polymerase η Opposite Benzo[a]pyrene 7,8-Diol 9,10-Epoxide Deoxyguanosine Adducts*
暂无分享,去创建一个
D. Jerina | F. Hanaoka | C. Masutani | J. M. Sayer | H. Kroth | A. Cheh | D. Chiapperino | Irene H. Kramarczuk
[1] Y. Fujii‐Kuriyama,et al. Expression of human and mouse genes encoding polκ: testis‐specific developmental regulation and AhR‐dependent inducible transcription , 2001, Genes to cells : devoted to molecular & cellular mechanisms.
[2] R. Woodgate,et al. Crystal Structure of a Y-Family DNA Polymerase in Action A Mechanism for Error-Prone and Lesion-Bypass Replication , 2001, Cell.
[3] C. Kisker,et al. Error-Prone DNA Polymerases Novel Structures and the Benefits of Infidelity , 2001, Cell.
[4] T. Steitz,et al. Crystal structure of a DinB lesion bypass DNA polymerase catalytic fragment reveals a classic polymerase catalytic domain. , 2001, Molecular cell.
[5] Robert E. Johnson,et al. Structure of the catalytic core of S. cerevisiae DNA polymerase eta: implications for translesion DNA synthesis. , 2001, Molecular cell.
[6] Z. Livneh. DNA Damage Control by Novel DNA Polymerases: Translesion Replication and Mutagenesis* , 2001, The Journal of Biological Chemistry.
[7] T. Kunkel,et al. The Y-family of DNA polymerases. , 2001, Molecular cell.
[8] D. Jerina,et al. O(6)-allyl protected deoxyguanosine adducts of polycyclic aromatic hydrocarbons as building blocks for the synthesis of oligonucleotides. , 2001, Chemical research in toxicology.
[9] S. Broyde,et al. Evading the proofreading machinery of a replicative DNA polymerase: induction of a mutation by an environmental carcinogen. , 2001, Journal of molecular biology.
[10] Robert E. Johnson,et al. Role of DNA Polymerase η in the Bypass of a (6-4) TT Photoproduct , 2001, Molecular and Cellular Biology.
[11] A. Grollman,et al. Influence of flanking sequence context on the mutagenicity of acetylaminofluorene-derived DNA adducts in mammalian cells. , 2001, Biochemistry.
[12] Yanbin Zhang,et al. Error-prone lesion bypass by human DNA polymerase eta. , 2000, Nucleic acids research.
[13] Fenghua Yuan,et al. Error-free and error-prone lesion bypass by human DNA polymerase κ in vitro , 2000 .
[14] M. Goodman,et al. The expanding polymerase universe , 2000, Nature Reviews Molecular Cell Biology.
[15] Robert E. Johnson,et al. Efficient and accurate replication in the presence of 7,8-dihydro-8-oxoguanine by DNA polymerase η , 2000, Nature Genetics.
[16] Satya Prakash,et al. Eukaryotic polymerases ι and ζ act sequentially to bypass DNA lesions , 2000, Nature.
[17] F. Hanaoka,et al. Mechanisms of accurate translesion synthesis by human DNA polymerase η , 2000, The EMBO journal.
[18] Chikahide Masutani,et al. Low fidelity DNA synthesis by human DNA polymerase-η , 2000, Nature.
[19] F. Hanaoka,et al. Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta. , 2000, Biochemistry.
[20] Satya Prakash,et al. Fidelity of Human DNA Polymerase η* , 2000, The Journal of Biological Chemistry.
[21] H. Nasheuer,et al. Eukaryotic DNA polymerases, a growing family. , 2000, Trends in biochemical sciences.
[22] R. Fuchs,et al. Lesions in DNA: hurdles for polymerases. , 2000, Trends in biochemical sciences.
[23] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[24] T. Lindahl,et al. Quality control by DNA repair. , 1999, Science.
[25] D. Jerina,et al. Characterization of the mutational profile of (+)-7R,8S-dihydroxy-9S, 10R-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene at the hypoxanthine (guanine) phosphoribosyltransferase gene in repair-deficient Chinese hamster V-H1 cells. , 1999, Carcinogenesis.
[26] Robert E. Johnson,et al. Bridging the gap: a family of novel DNA polymerases that replicate faulty DNA. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[27] D. Jerina,et al. Dose-dependent mutation profile in the c-Ha-ras proto-oncogene of skin tumors in mice initiated with benzo[a]pyrene. , 1999, Carcinogenesis.
[28] R. Woodgate. A plethora of lesion-replicating DNA polymerases. , 1999, Genes & development.
[29] E. Friedberg,et al. Novel DNA Polymerases Offer Clues to the Molecular Basis of Mutagenesis , 1999, Cell.
[30] Robert E. Johnson,et al. hRAD30 mutations in the variant form of xeroderma pigmentosum. , 1999, Science.
[31] R. Wood. DNA repair: Variants on a theme , 1999, Nature.
[32] Chikahide Masutani,et al. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase η , 1999, Nature.
[33] F. Hanaoka,et al. Xeroderma pigmentosum variant (XP‐V) correcting protein from HeLa cells has a thymine dimer bypass DNA polymerase activity , 1999, The EMBO journal.
[34] Samuel H. Wilson,et al. “Action-at-a-Distance” Mutagenesis , 1999, The Journal of Biological Chemistry.
[35] Robert E. Johnson,et al. Efficient bypass of a thymine-thymine dimer by yeast DNA polymerase, Poleta. , 1999, Science.
[36] D. Jerina,et al. Sequence context profoundly influences the mutagenic potency of trans-opened benzo[a]pyrene 7,8-diol 9,10-epoxide-purine nucleoside adducts in site-specific mutation studies. , 1998, Biochemistry.
[37] D. Patel,et al. Structural alignment of the (+)-trans-anti-benzo[a]pyrene-dG adduct positioned opposite dC at a DNA template-primer junction. , 1997, Biochemistry.
[38] W. Kaufmann,et al. Replication Fork Bypass of a Pyrimidine Dimer Blocking Leading Strand DNA Synthesis* , 1997, The Journal of Biological Chemistry.
[39] D. Patel,et al. Solution conformation of the (-)-cis-anti-benzo[a]pyrenyl-dG adduct opposite dC in a DNA duplex: intercalation of the covalently attached BP ring into the helix with base displacement of the modified deoxyguanosine into the major groove. , 1996, Biochemistry.
[40] D. Patel,et al. Structural alignments of (+)- and (-)-trans-anti-benzo[a]pyrene-dG adducts positioned at a DNA template-primer junction. , 1995, Biochemistry.
[41] D. Jerina,et al. Mutagenic selectivity at the HPRT locus in V-79 cells: comparison of mutations caused by bay-region benzo[a]pyrene 7,8-diol-9,-10-epoxide enantiomers with high and low carcinogenic activity. , 1994, Carcinogenesis.
[42] R H Sarma,et al. Structural Biology: The State of the Art. , 1994, Journal of biomolecular structure & dynamics.
[43] D. Jerina,et al. Dose-dependent differences in the profile of mutations induced by (+)-7R,8S-dihydroxy-9S,10R-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene in the coding region of the hypoxanthine (guanine) phosphoribosyltransferase gene in Chinese hamster V-79 cells. , 1993, Cancer research.
[44] D. Patel,et al. Solution conformation of the (+)-cis-anti-[BP]dG adduct in a DNA duplex: intercalation of the covalently attached benzo[a]pyrenyl ring into the helix and displacement of the modified deoxyguanosine. , 1993, Biochemistry.
[45] T. Krugh,et al. Structural characterization of an N-acetyl-2-aminofluorene (AAF) modified DNA oligomer by NMR, energy minimization, and molecular dynamics. , 1993, Biochemistry.
[46] D. Patel,et al. Solution conformation of the major adduct between the carcinogen (+)-anti-benzo[a]pyrene diol epoxide and DNA. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[47] D. Patel,et al. NMR structural studies of the ionizing radiation adduct 7-hydro-8-oxodeoxyguanosine (8-oxo-7H-dG) opposite deoxyadenosine in a DNA duplex. 8-Oxo-7H-dG(syn).dA(anti) alignment at lesion site. , 1991, Biochemistry.
[48] D. Jerina,et al. Metabolism of benzo[a]pyrene. VI. Stereoselective metabolism of benzo[a]pyrene and benzo[a]pyrene 7,8-dihydrodiol to diol epoxides. , 1977, Chemico-biological interactions.
[49] M. D. Topal,et al. Complementary base pairing and the origin of substitution mutations , 1976, Nature.
[50] S. Creighton,et al. Gel fidelity assay measuring nucleotide misinsertion, exonucleolytic proofreading, and lesion bypass efficiencies. , 1995, Methods in enzymology.
[51] D. Jerina,et al. Covalent nucleoside adducts of benzo[a]pyrene 7,8-diol 9,10-epoxides: structural reinvestigation and characterization of a novel adenosine adduct on the ribose moiety , 1991 .
[52] D. Jerina,et al. Covalent bonding of bay-region diol epoxides to nucleic acids. , 1991, Advances in experimental medicine and biology.
[53] D. Jerina,et al. Reactivity and tumorigenicity of bay-region diol epoxides derived from polycyclic aromatic hydrocarbons. , 1986, Advances in experimental medicine and biology.
[54] D. Parke,et al. Biological Reactive Intermediates , 1977, Springer US.